Related Experiment Video
Updated: Jul 3, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1.
Anita H Lewin1, Hernán A Navarro, S Wayne Mascarella
1Center for Organic and Medicinal Chemistry, RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709-2194, USA. ahl@rti.org
Bioorganic & Medicinal Chemistry
|July 8, 2008
Summary
Researchers evaluated beta-phenethylamines using a cell line expressing the human trace amine-associated receptor 1 (hTAAR1). Bulky substituents and N-methylation resulted in partial agonists, indicating low efficacy ligands.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Molecular Biology
Background:
- Trace amine-associated receptor 1 (TAAR1) is a G protein-coupled receptor involved in neurological processes.
- Beta-phenethylamines are a class of compounds with diverse biological activities, some interacting with TAAR1.
Purpose of the Study:
- To systematically evaluate the structure-activity relationships of beta-phenethylamine analogs at the human TAAR1 receptor.
- To identify key structural features influencing ligand efficacy and potency.
Main Methods:
- Development of a stable cell line (RD-HGA16) expressing the human TAAR1 receptor.
- Functional assaying of beta-phenethylamine analogs for receptor activation.
- Comparative Molecular Field Analysis (CoMFA) to model structure-activity relationships.
Main Results:
- Multiple substituents and bulky groups on beta-phenethylamines led to partial agonist activity.
- N-methylation of the primary amino group also resulted in partial agonism.
- CoMFA analysis showed a strong correlation (r(2) = 0.824) with steric and electrostatic contributions.
Conclusions:
- Increasing steric bulk at the amino nitrogen (e.g., N-dimethylation) and the 4-position of the aromatic ring reduces ligand efficacy.
- Structural modifications can fine-tune the agonist profile of beta-phenethylamines at hTAAR1.
Related Concept Videos
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:26Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...